Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies

Immunology

Volumn 104, Issue 2, 2001, Pages 215-225

  Lin, Feng ^a   Fukuoka, Yoshihiro ^a   Spicer, Andrew ^b   Ohta, Rieko ^c   Okada, Noriko ^c   Harris, Claire L ^d   Emancipator, Steven N ^a   Edward Medof, M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DECAY ACCELERATING FACTOR; GENE PRODUCT; ISOPROPAMIDE IODIDE; MONOCLONAL ANTIBODY;

AIRWAY; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DENDRITIC CELL; GENE TARGETING; GLOMERULUS; INTESTINE EPITHELIUM; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINIFEROUS TUBULE; SPLEEN; TESTIS; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM; YEAST;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD55; BINDING SITES; CAENORHABDITIS ELEGANS PROTEINS; COMPLEMENT C3; CYCLINS; FUNGAL PROTEINS; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, INSULIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE PROTEINS; TISSUE DISTRIBUTION;

EID: 0034776676     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01287.x     Document Type: Article

References (55)

1. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes
2. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system
3. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria
4. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociated C2a and Bb
5. The gene encoding decay-accelerating factor (DAF) is located in the complement regulatory locus on the long arm of chromosome 1
6. Decay-accelerating factor of complement is anchored to cells by a C-terminal glycolipid
7. Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PI-PLC)
8. Amelioration of the lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor
9. Decay-accelerating factor (DAF) protects human tumor cells from complement-mediated cytotoxicity in vitro
10. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury
11. Xenogeneic transplantation
12. Splenectomy improves survival of HDAF transgenic pig kidneys in primates
13. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55/DAF)
14. Molecular cloning and characterization of mouse CD97
15. Murine membrane inhibitor of complement which accelerates decay of human C3 convertase
16. Molecular cloning of murine decay accelerating factor by immunoscreening
17. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms
18. Mouse decay-accelerating factor. Selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form
19. Characterization of mouse DAF on transfectant cells using monoclonal antibodies which recognize different epitopes
20. Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells
21. Generation of mice with a 200-kb amyloid precursor protein gene deletion by Cre recombinase-mediated site-specific recombination in embryonic stem cells
22. The intracellular production and secretion of HIV-1 envelope protein in the methylotrophic yeast Pichia pastoris
23. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies
24. Chromosome engineering in mice
25. Biosynthesis and glycosylation of the complement regulatory protein decay accelerating factor
26. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor
27. Structure/function studies of human decay accelerating factor (DAF)
28. Conservation in decay accelerating factor (DAF) structure among primates
29. Characterization of the active site in decay-accelerating factor (DAF)
30. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting
31. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing
32. Alternative exon usage in the 3′ region of a single gene generates glycosyl-phosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor
33. Functional differences among multiple isoforms of guinea pig decay-accelerating factor
34. Molecular analysis of two closely related mouse decay-accelerating factor (CD55, DAF) genes: Identification in both of sequences encoding glycosylphosphatidylinositol-anchored and transmembrane forms of DAF
35. Molecular and functional analysis of mouse decay accelerating factor (CD55)
36. Tissue distribution of the rat analogue of decay-accelerating factor
37. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids
38. Tissue distribution of the guinea-pig decay-accelerating factor
39. Fluorochrome-labeled tyramides: Use in immunocytochemistry and fluorescence in situ hybridization
40. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis
41. Functional properties of membrane cofactor protein of complement
42. Cooperation between decay accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack
43. A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement
44. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells
45. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria
46. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1): And Crry, the two genetic homologues of human CR1
47. The evolution of mouse and human complement C3-binding proteins: Divergence of form but conservation of function
48. Molecular cloning of the rat complement regulatory protein, 5-I-2 antigen
49. Complement inhibitor of rat cell membrane resembling mouse Crry/p65
50. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF
51. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein
52. Tissue distribution of complement regulatory membrane proteins in rats
53. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): Preferential expression in testicular germ cells
54. Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): Preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1
55. Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46)